Currently out of the existing stock ratings of Ying Huang, 36 are a BUY (81.82%), 7 are a HOLD (15.91%), 1 are a SELL (2.27%).

Ying Huang

Work Performance Price Targets & Ratings Chart

Analyst Ying Huang, carries an average stock price target met ratio of 78.8% that have a potential upside of 32.52% achieved within 272 days.

Ying Huang’s has documented 107 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 10-Mar-2026.

Wall Street Analyst Ying Huang

Analyst best performing recommendations are on ESPR (ESPERION THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 5/2/2018. The price target of $44 was fulfilled within 1 day with a profit of $1.75 (3.83%) receiving and performance score of 38.25.

Average potential price target upside

of $675 (76.75%) on BLUE (BLUEBIRD BIO).
of $61.48 (47.51%) on AMGN (AMGEN).
of $41.72 (70.36%) on LUMO (LUMOS PHARMA).

ALXN Alexion Pharmaceuticals BMRN Biomarin Pharmaceutical CELG Celgene BGNE BeiGene Ltd BIIB Biogen VRTX Vertex Pharmaceuticals BLUE Bluebird bio PBYI Puma Biotechnology ICPT Intercept Pharmaceuticals AMGN Amgen ESPR Esperion Therapeutics KPTI Karyopharm Therapeutics LUMO Lumos Pharma NLNK NewLink Genetics YMAB Y mAbs Therapeutics HOOK Hookipa Pharma MRNA Moderna RCKT Rocket Pharmaceuticals RGNX Regenxbio

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hartaj Singh (OPPENHEIMER)